ANL 28.76 Increased By ▲ 0.41 (1.45%)
ASC 15.27 Increased By ▲ 0.13 (0.86%)
ASL 24.01 Increased By ▲ 0.36 (1.52%)
AVN 97.55 Increased By ▲ 1.95 (2.04%)
BOP 9.25 Increased By ▲ 0.05 (0.54%)
BYCO 10.41 Increased By ▲ 0.34 (3.38%)
DGKC 135.52 Increased By ▲ 3.02 (2.28%)
EPCL 49.25 Increased By ▲ 0.55 (1.13%)
FCCL 25.30 Increased By ▲ 0.75 (3.05%)
FFBL 25.41 Decreased By ▼ -0.22 (-0.86%)
FFL 16.00 No Change ▼ 0.00 (0%)
HASCOL 11.04 Decreased By ▼ -0.02 (-0.18%)
HUBC 84.80 Increased By ▲ 0.60 (0.71%)
HUMNL 7.80 Increased By ▲ 0.53 (7.29%)
JSCL 25.50 Increased By ▲ 0.85 (3.45%)
KAPCO 37.51 Increased By ▲ 1.41 (3.91%)
KEL 4.17 Increased By ▲ 0.12 (2.96%)
LOTCHEM 15.10 Increased By ▲ 0.34 (2.3%)
MLCF 47.10 Increased By ▲ 1.10 (2.39%)
PAEL 39.52 Increased By ▲ 0.77 (1.99%)
PIBTL 12.03 Decreased By ▼ -0.02 (-0.17%)
POWER 10.79 Increased By ▲ 0.19 (1.79%)
PPL 91.20 Increased By ▲ 0.60 (0.66%)
PRL 26.70 Increased By ▲ 0.40 (1.52%)
PTC 9.05 Decreased By ▼ -0.09 (-0.98%)
SILK 1.44 Increased By ▲ 0.04 (2.86%)
SNGP 38.90 Decreased By ▼ -0.10 (-0.26%)
TRG 146.80 Increased By ▲ 8.05 (5.8%)
UNITY 33.00 Increased By ▲ 0.85 (2.64%)
WTL 1.61 Increased By ▲ 0.05 (3.21%)
BR100 4,965 Increased By ▲ 91.3 (1.87%)
BR30 25,752 Increased By ▲ 516.42 (2.05%)
KSE100 45,969 Increased By ▲ 606.81 (1.34%)
KSE30 19,214 Increased By ▲ 329.46 (1.74%)

ISLAMABAD: AstraZeneca’s COVID-19 vaccine has been approved for emergency use in Pakistan, Special Assistant to Prime Minister Dr Faisal Sultan said on Saturday, making it the first coronavirus vaccine to get the green light for use in the South Asian country.

Pakistan, which is seeing rising numbers of coronavirus infections, said its vaccines would be procured from multiple sources.

"DRAP granted emergency use authorisation to AstraZeneca’s COVID vaccine," Faisal Sultan told Reuters.

Approval has been given to get more than a million doses of Sinopharm’s vaccine from China, he said.

“We are in the process to obtain Western origin and other vaccines both via bilateral purchase agreements as well as via the COVAX facility,” he said.

The Chinese vaccine is awaiting approval from the Drug Regulatory Authority of Pakistan (DRAP), which has received and reviewed its data.

Pakistan is speaking to a number of vaccine makers, and Sultan said the country could get "in the range of tens of millions" of vaccine doses under an agreement with China’s CanSinoBio.

The vaccine company’s Ad5-nCoV COVID-19 candidate is nearing completion of Phase III clinical trials in Pakistan.

Efficacy is a key factor, said Sultan. "We have and are watching the evolving stories around efficacy of a number of vaccines."

Sultan said preliminary results of the Cansino may come in by mid-February. He added that Pakistan was considering to engage with Russia’s Sputnik V vaccine.

Pakistan reported 2,432 new coronavirus infections and 45 deaths on Friday, taking the total number of cases to more than 516,000 and deaths close to 11,000.

"Our aim is that the bulk of the population will be covered free," the minister said, adding that private sectors could also be allowed once supply was available to an authorized company.

Sultan added that Pakistan had adequate cold chain facilities for most kinds of vaccines.